These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3073992)

  • 21. [Therapy with calcium antagonists in acute myocardial infarction. Hemodynamic evaluation using the hand-grip test].
    Ravazzi PA; Ivaldi M; Priolo C; Fornari P; Carosio G; Provera PF; Guarraggi F
    Minerva Cardioangiol; 1986; 34(7-8):511-6. PubMed ID: 3774166
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of calcium antagonists in the treatment of cardiac insufficiency].
    Moret P
    Ther Umsch; 1984 Feb; 41(2):125-30. PubMed ID: 6369615
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium channel blockers.
    Dipalma JR
    Am Fam Physician; 1983 Feb; 27(2):283-5. PubMed ID: 6829383
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension: calcium-blocking agents in treatment.
    Ambrose JE
    J Am Osteopath Assoc; 1984 Jan; 83(5):353-60. PubMed ID: 6321407
    [No Abstract]   [Full Text] [Related]  

  • 26. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons.
    Alps BJ; Calder C; Wilson A
    Arzneimittelforschung; 1983; 33(6):868-76. PubMed ID: 6684443
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium antagonists in the treatment early after myocardial infarction. The DEFIANT Research Group.
    Schartl M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S79-81. PubMed ID: 1282620
    [No Abstract]   [Full Text] [Related]  

  • 30. Review of calcium-channel blockers.
    Stowe HO
    Nurse Pract; 1986 Apr; 11(4):57-8, 60, 65. PubMed ID: 3515244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of calcium channel blockers.
    Galle JS
    Conn Med; 1983 Oct; 47(10):605-10. PubMed ID: 6627936
    [No Abstract]   [Full Text] [Related]  

  • 33. [Calcium antagonists in ischemic heart disease].
    Sadowski Z; Kośmicki M; Skorykow-Sapińska A
    Kardiol Pol; 1987; 30 Suppl():44-9. PubMed ID: 3454384
    [No Abstract]   [Full Text] [Related]  

  • 34. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blocking drugs.
    Johnston WE; Lowenstein E
    Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
    [No Abstract]   [Full Text] [Related]  

  • 36. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary note on the use of calcium antagonists in ischemic cardiopathy].
    Seu V; Abrile PG; Boero E; Magaia O; Mocini A; Castrignano A; Maffei P; Perugini P; Livi A
    Minerva Cardioangiol; 1984 Oct; 32(10):639-46. PubMed ID: 6396533
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
    Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):497-8. PubMed ID: 7058761
    [No Abstract]   [Full Text] [Related]  

  • 40. Why Ca2+ antagonists will be most useful before or during early myocardial ischemia and not after infarction has been established. Danish Study Group on Verapamil in Myocardial Infarction.
    Hansen JF
    Eur Heart J; 1986 Oct; 7(10):910-1. PubMed ID: 3792353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.